Key Takeaways
- • Sukino raised $31 million in Series B funding led by Bessemer Venture Partners, with participation from Rainmatter, to expand its out-of-hospital post-acute care operations across India.
- • The company operates 850+ beds across eleven centres in Bengaluru, Kochi, and Coimbatore, with primary focus on stroke rehabilitation and secondary services for neurological, orthopaedic, and oncology conditions.
- • Sukino is positioned to capitalize on expanding insurance coverage for rehabilitation care (60-90 days of structured recovery now covered by multiple health plans) and growing acceptance of institutional recovery services among patients and families.
- • India accounts for approximately 10% of global stroke cases annually, with incidence rising due to obesity, sedentary lifestyles, hypertension, stress, and air pollution—creating a significant addressable market for post-acute care services.
- • The company operates profitably at the group level and plans to deploy capital for geographic expansion, addressing a market gap where families increasingly prefer specialized institutional recovery over home-based care.
Summary
Sukino, a post-acute care healthcare chain, announced a $31 million Series B funding round led by premier venture capital firm Bessemer Venture Partners, with co-investment from Rainmatter. The capital will be deployed for geographical expansion of the company's out-of-hospital rehabilitation services across India.
Founded in 2016 by Rajinish Menon and Shalini Menon, Sukino operates as a specialized continuum care provider focused on patient recovery during the rehabilitation phase following hospital discharge. The company currently maintains 850+ licensed beds distributed across eleven centers in three major metros: Bengaluru, Kochi, and Coimbatore. While stroke rehabilitation represents the primary clinical focus, the centers also serve patients requiring recovery support for neurological, orthopaedic, and oncology conditions. The company has achieved profitability at the group level, indicating operational efficiency and market validation.
The investment thesis reflects structural tailwinds in India's healthcare landscape. The country accounts for approximately 10% of global stroke cases annually, with incidence rising due to lifestyle and environmental factors including obesity, sedentary behaviors, hypertension, psychological stress, and air pollution. Post-acute stroke patients typically require six to eight weeks of structured rehabilitation involving physical, occupational, speech, and psychological therapy. Sukino's model addresses this care requirement through specialized institutional settings positioned strategically between hospitals and residential areas.
A critical enabler for Sukino's growth trajectory is the expansion of insurance coverage architecture. Multiple health insurance plans now cover 60 to 90 days of structured post-hospitalization recovery care, substantially reducing out-of-pocket expenses for patients and families. This coverage expansion, combined with shifting consumer preferences toward specialized institutional care over home-based recovery, has expanded addressable market demand. Families increasingly recognize clinical outcomes and quality-of-life improvements associated with dedicated rehabilitation facilities, reversing historical resistance to out-of-home recovery services.
The Series B round provides Sukino with capital to execute geographic expansion and deepen market penetration in existing and new regions, capitalizing on favorable regulatory, insurance, and consumer trends in India's post-acute care sector.
Founded in 2016 by Rajinish Menon and Shalini Menon, Sukino operates as a specialized continuum care provider focused on patient recovery during the rehabilitation phase following hospital discharge. The company currently maintains 850+ licensed beds distributed across eleven centers in three major metros: Bengaluru, Kochi, and Coimbatore. While stroke rehabilitation represents the primary clinical focus, the centers also serve patients requiring recovery support for neurological, orthopaedic, and oncology conditions. The company has achieved profitability at the group level, indicating operational efficiency and market validation.
The investment thesis reflects structural tailwinds in India's healthcare landscape. The country accounts for approximately 10% of global stroke cases annually, with incidence rising due to lifestyle and environmental factors including obesity, sedentary behaviors, hypertension, psychological stress, and air pollution. Post-acute stroke patients typically require six to eight weeks of structured rehabilitation involving physical, occupational, speech, and psychological therapy. Sukino's model addresses this care requirement through specialized institutional settings positioned strategically between hospitals and residential areas.
A critical enabler for Sukino's growth trajectory is the expansion of insurance coverage architecture. Multiple health insurance plans now cover 60 to 90 days of structured post-hospitalization recovery care, substantially reducing out-of-pocket expenses for patients and families. This coverage expansion, combined with shifting consumer preferences toward specialized institutional care over home-based recovery, has expanded addressable market demand. Families increasingly recognize clinical outcomes and quality-of-life improvements associated with dedicated rehabilitation facilities, reversing historical resistance to out-of-home recovery services.
The Series B round provides Sukino with capital to execute geographic expansion and deepen market penetration in existing and new regions, capitalizing on favorable regulatory, insurance, and consumer trends in India's post-acute care sector.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.